![Diantha Duvall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Diantha Duvall
Director of Finance/CFO at
CURIS, INC.
Net worth: 19 503 $ as of 2026-07-30
Profile
Diantha Duvall is currently Director at BioTheryX, Inc. since 2021 and CFO, Treasurer & Chief Accounting Officer at Curis, Inc. since 2022.
Former positions include Executive Director at Merck & Co., Inc. from 2009 to 2015, Global Commercial Controller at Biogen, Inc. from 2016 to 2017, Chief Accounting Officer, VP & Controller at Bioverativ, Inc. from 2017 to 2019, and Chief Financial Officer at Genocea Biosciences, Inc. from 2019 to 2022.
Education includes undergraduate studies at Colby College and graduate studies including an MBA at Northeastern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CURIS, INC. 0.2% | 2026-07-06 | 3,885 ( 0.2% ) | 19 503 $ | 2026-07-30 |
Diantha Duvall active positions
| Companies | Position | Start |
|---|---|---|
| CURIS, INC. | Director of Finance/CFO | 2022-08-04 |
BioTheryX, Inc.
 BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Director/Board Member | 2021-08-08 |
Former positions of Diantha Duvall
| Companies | Position | End |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Director of Finance/CFO | 2022-06-30 |
| BIOVERATIV INC | Comptroller/Controller/Auditor | 2018-12-31 |
| BIOGEN INC. | Corporate Officer/Principal | 2016-12-31 |
| MERCK & CO., INC. | Director/Board Member | 2014-12-31 |
Training of Diantha Duvall
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
Colby College
 Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
- Stock Market
- Insiders
- Diantha Duvall
